The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Industry s Direct’s proprietary databases, Firms ’s corporate website, SEC filings, investor presentations and featured press releases, both from industry player and market -specific third party sources, put together by Global Industry s Direct’s team.

Scope of the Research

- Istituto Clinico Humanitas - Brief industry player overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Istituto Clinico Humanitas human therapeutic division.
- Detailed Analysis of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Istituto Clinico Humanitas with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Istituto Clinico Humanitas’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Why Should You Get This Report?

- Evaluate Istituto Clinico Humanitas’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Istituto Clinico Humanitas in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Istituto Clinico Humanitas’s Research and Development portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Istituto Clinico Humanitas.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Istituto Clinico Humanitas and identify potential opportunities in those areas.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Istituto Clinico Humanitas Snapshot 5
Istituto Clinico Humanitas Overview 5
Key Information 5
Key Facts 5
Istituto Clinico Humanitas - Research and Development Overview 6
Key Therapeutic Areas 6
Istituto Clinico Humanitas - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Combination Treatment Modalities 11
Istituto Clinico Humanitas - Pipeline Products Glance 12
Istituto Clinico Humanitas Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 14
Istituto Clinico Humanitas - Drug Profiles 15
BAY-43-9006 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
Bortezomib + IGEV 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
Carboplatin + Alimta 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
Doxorubicin + Ifosfamide 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
Gemcitabine 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
Lenalidomide + Dexamethasone 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
Oral Vorinostat + Topotecan 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
Pegfilgrastim 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
Revlimid + Dexamethasone 25
Product Description 25
Mechanism of Action 25
RandD Progress 25
Suberoylanilide Hydroxamic Acid + Topotecan 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
Sunitinib 28
Product Description 28
Mechanism of Action 28
RandD Progress 28
TLC D-99 + ifosfamide 29
Product Description 29
Mechanism of Action 29
RandD Progress 29
Trastuzumab 30
Product Description 30
Mechanism of Action 30
RandD Progress 30
Lapatinib + Sorafenib 31
Product Description 31
Mechanism of Action 31
RandD Progress 31
Istituto Clinico Humanitas - Pipeline Analysis 32
Istituto Clinico Humanitas - Pipeline Products by Therapeutic Class 32
Istituto Clinico Humanitas Pipeline Products By Target 34
Istituto Clinico Humanitas - Pipeline Products by Route of Administration 36
Istituto Clinico Humanitas - Pipeline Products by Molecule Type 37
Istituto Clinico Humanitas - Locations And Subsidiaries 38
Head Office 38
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 40
Contact Us 40
Disclaimer 40List of Tables
Istituto Clinico Humanitas - Pipeline by Therapy Area and Indication, 2010 7
Istituto Clinico Humanitas - Pipeline by Stage of Development, 2010 9
Istituto Clinico Humanitas - Monotherapy Products in Pipeline, 2010 10
Istituto Clinico Humanitas - Combination Treatment Modalities in Pipeline, 2010 11
Istituto Clinico Humanitas - Phase II, 2010 12
Istituto Clinico Humanitas - Phase I, 2010 14
Istituto Clinico Humanitas - Pipeline By Therapeutic Class, 2010 32
Istituto Clinico Humanitas - Pipeline By Target, 2010 34
Istituto Clinico Humanitas - Pipeline By Route of Administration, 2010 36
Istituto Clinico Humanitas - Pipeline By Molecule Type, 2010 37

List of Figures
Istituto Clinico Humanitas - Pipeline by Therapy Area and Indication, 2010 7
Istituto Clinico Humanitas - Pipeline by Stage of Development, 2010 9
Istituto Clinico Humanitas - Monotherapy Products in Pipeline, 2010 10
Istituto Clinico Humanitas - Combination Treatment Modalities in Pipeline, 2010 11
Istituto Clinico Humanitas - Pipeline By Therapeutic Class, 2010 32
Istituto Clinico Humanitas - Pipeline By Target, 2010 34
Istituto Clinico Humanitas - Pipeline By Route of Administration, 2010 36

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Diagnostics and Therapeutics for HIV: Global Markets

Diagnostics and Therapeutics for HIV: Global Markets

  • $ 6 650
  • Industry report
  • April 2014
  • by BCC Research

STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for products used in the treatment, testing ...

JAK and PI3K Signaling Pathway Markets

JAK and PI3K Signaling Pathway Markets

  • $ 6 650
  • Industry report
  • April 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion ...

Therapeutics for Women%s Health: Technologies and Global Markets

Therapeutics for Women%s Health: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Learn about the main women's health disorders and relevant disease prevalence population. - Identify the impact of demographic, economic, and other factors that will drive future ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.